Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pediatrics

Building Your Child's Complex Care Team

At a Glance

For a child with agammaglobulinemia, microcephaly, craniosynostosis, and severe dermatitis syndrome, a central care coordinator can connect immunology, craniofacial surgery, genetics, dermatology, neurology, and developmental services through one shared plan.

Managing a condition as complex and ultra-rare as this syndrome requires more than just good doctors; it requires a highly coordinated multidisciplinary team. Because this condition affects the immune system, the brain, the skull, and the skin, no single specialist can manage it alone.

In the rare disease community, the most successful model is often called a medical home [1]. This is not a building, but a way of organizing care where one clinician—often a complex care pediatrician—acts as a coordinator to ensure that all specialists are working from the same playbook [2][3]. As a parent, you are a crucial partner, but you are not expected to be the doctor or the sole coordinator of this care.

Assembling Your Core Team

A child with this syndrome typically needs regular follow-up with several key specialists. Your “starting lineup” should include:

  • Clinical Immunologist: The lead for managing agammaglobulinemia. They oversee immunoglobulin replacement therapy, monitor B-cell maturation, and create your emergency fever plan [4][5].
  • Craniofacial Team (Neurosurgery & Plastic Surgery): These specialists work together to monitor the skull’s growth and plan any necessary surgeries for craniosynostosis or a cleft palate [6][7].
  • ENT, Ophthalmology, and Audiology: Critical for evaluating choanal narrowing, managing ptosis or amblyopia associated with blepharophimosis, and monitoring for recurrent ear disease.
  • Medical Geneticist: Essential for the “unsolved” journey. They coordinate Whole Exome or Whole Genome Sequencing and oversee periodic review of your child’s data as new genes are discovered [8][9].
  • Pediatric Dermatologist: Focuses on the “barrier repair” of severe dermatitis to prevent the skin from becoming a gateway for infections [10].
  • Neurologist & Developmental Pediatrician: To monitor brain development, manage any seizure risks based on symptoms, and coordinate therapies for developmental delays [11][12].
  • Social Work and Feeding Specialists: To assist the family with insurance, school accommodations, travel, and nutritional support.

The Power of Coordinated Care

With so many specialists, care can quickly become fragmented. A central point person—which can be a pediatrician, a nurse practitioner, or even a dedicated care coordinator—is responsible for maintaining a shared care plan [13][1].

This person ensures that the neurosurgeon knows what the immunologist recommended regarding antibiotics before surgery, and that the dermatologist’s skin treatments don’t interfere with the IVIg infusion sites. Proactive coordination, such as pre-visit calls and shared goal-setting, has been shown to reduce emergency room visits and family stress [14][15].

Organizing for the ‘Unsolved’ Journey

Because you are dealing with an ultra-rare and currently “unsolved” condition, you will often hold the most comprehensive history regarding your child’s specific timeline.

  • Create a Master Binder: Keep physical or digital copies of every immunology report (IgG trough levels, B-cell counts), genetic test result (including raw data if possible), operative notes, and discharge summaries [16][17].
  • The One-Page Summary: Create a “cheat sheet” for new doctors that lists the 2006 Crow et al. reported phenotype, current medications (especially immunoglobulin doses), allergies, and clear “red flags” for your child.
  • Seek Research Networks: If standard testing is negative, your team may suggest a referral to a program like the Undiagnosed Diseases Network (UDN) or the Solve-RD consortium, which use advanced research tools to find answers for families without a genetic diagnosis [18][19]. Availability of these programs depends on your country and specific eligibility criteria; always discuss privacy and consent before sharing genomic data.

Your role as a parent is not to be the doctor, but to be the advocate and the keeper of the “big picture.” By building a team that values your input and communicates openly with one another, you can ensure your child receives the most cohesive care possible [17][20].

Common questions in this guide

Who should be the main coordinator for my child's medical care?
A complex care pediatrician, pediatrician, nurse practitioner, or dedicated care coordinator can serve as the central point person. This person maintains the shared care plan and helps specialists communicate about treatments, procedures, and follow-up.
What specialists should be on my child's care team?
The team commonly includes a clinical immunologist, craniofacial neurosurgery and plastic surgery specialists, ENT, ophthalmology, audiology, medical genetics, pediatric dermatology, neurology, and developmental pediatrics. Social work and feeding specialists can also help with practical, school, travel, and nutrition needs.
How should immune care be coordinated before craniosynostosis or cleft palate surgery?
The surgical and immunology teams should share a plan before any operation. They can coordinate infection prevention, antibiotic recommendations, immunoglobulin treatment, and the timing of infusions with the procedure.
What medical records should I keep for a child with this syndrome?
Keep immunology reports such as IgG trough levels and B-cell counts, genetic test results and raw data when available, operative notes, discharge summaries, medication doses, allergies, and warning signs. A one-page summary can help new clinicians quickly understand the child's history and current needs.
What can we do if genetic testing does not identify the cause?
Ask the medical geneticist whether periodic review, whole-exome or whole-genome sequencing, or referral to an undiagnosed-diseases program is appropriate. Programs such as the Undiagnosed Diseases Network or Solve-RD may use research tools, but eligibility varies and families should discuss privacy and consent before sharing genomic data.
How can parents help coordinate care without managing every medical decision?
Parents can act as advocates and keep the overall history, priorities, and records organized while the designated coordinator handles communication among clinicians. Sharing quality-of-life goals and new reports helps the team keep the main care plan current.

Get notified when new evidence is published on Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    A Qualitative Study of Family Caregiver Perceptions of High-Quality Care at a Pediatric Complex Care Center.

    Yu JA, Cook S, Imming C, et al.

    Academic pediatrics 2022; (22(1)):107-115 doi:10.1016/j.acap.2021.05.012.

    PMID: 34020106
  2. 2

    Optimizing the multidisciplinary team to enhance care coordination across the continuum for children with medical complexity.

    Leach KF, Stack NJ, Jones S

    Current problems in pediatric and adolescent health care 2021; (51(12)):101128 doi:10.1016/j.cppeds.2021.101128.

    PMID: 35033456
  3. 3

    Pediatric Care Coordination: Lessons Learned and Future Priorities.

    Cady RG, Looman WS, Lindeke LL, et al.

    Online journal of issues in nursing 2015; (20(3)):3.

    PMID: 26882512
  4. 4

    Immunoglobulin replacement therapies in inborn errors of immunity: a review.

    Sil A, Basu S, Joshi V, et al.

    Frontiers in pediatrics 2024; (12()):1368755 doi:10.3389/fped.2024.1368755.

    PMID: 38425666
  5. 5

    A Novel Variant of the PIK3R1 Gene Mutation Associated With SHORT Syndrome and Agammaglobulinemia.

    Syed Iqbaluddin J, Cipe F, Al-Hammadi S, et al.

    Cureus 2024; (16(6)):e62983 doi:10.7759/cureus.62983.

    PMID: 39044864
  6. 6

    Physiological Changes and Clinical Implications of Syndromic Craniosynostosis.

    Sakamoto H, Matsusaka Y, Kunihiro N, Imai K

    Journal of Korean Neurosurgical Society 2016; (59(3)):204-13 doi:10.3340/jkns.2016.59.3.204.

    PMID: 27226850
  7. 7

    Updates in Cleft Care.

    Parham MJ, Simpson AE, Moreno TA, Maricevich RS

    Seminars in plastic surgery 2023; (37(4)):240-252 doi:10.1055/s-0043-1776733.

    PMID: 38098682
  8. 8

    Integrative and systematic genomic approaches to improve diagnosis in rare and undiagnosed diseases: results from the RareBoost project.

    Yigit A, Pekerbas M, Salman B, et al.

    European journal of human genetics : EJHG 2026; (34(10)):1473-1485 doi:10.1038/s41431-026-02177-9.

    PMID: 42426151
  9. 9

    Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.

    Wright CF, McRae JF, Clayton S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(10)):1216-1223 doi:10.1038/gim.2017.246.

    PMID: 29323667
  10. 10

    The prevalence of allergic manifestations in inborn errors of immunity: a retrospective cohort study.

    Esmaeilzadeh H, Esmaeilbeig M, Askarisarvestani A, et al.

    BMC immunology 2025; (26(1)):73 doi:10.1186/s12865-025-00758-9.

    PMID: 41023596
  11. 11

    Meningoencephalitis in primary antibody deficiency: Our experience from northwest India.

    Jindal AK, Chaudhary H, Tyagi R, et al.

    Journal of neuroimmunology 2022; (371()):577952 doi:10.1016/j.jneuroim.2022.577952.

    PMID: 36030644
  12. 12

    Neurodevelopmental Outcomes in 22 Children With Microcephaly of Different Etiologies.

    Gordon-Lipkin E, Gentner MB, German R, Leppert ML

    Journal of child neurology 2017; (32(9)):804-809 doi:10.1177/0883073817707301.

    PMID: 28482742
  13. 13

    The Goldilocks problem: Healthcare delivery models for children with medical complexity.

    Galligan MM, Hogan AK

    Current problems in pediatric and adolescent health care 2021; (51(12)):101127 doi:10.1016/j.cppeds.2021.101127.

    PMID: 35000837
  14. 14

    Care coordination over time in medical homes for children with special health care needs.

    Van Cleave J, Boudreau AA, McAllister J, et al.

    Pediatrics 2015; (135(6)):1018-26 doi:10.1542/peds.2014-1067.

    PMID: 25963012
  15. 15

    Implementation and Evaluation of a Wraparound Virtual Care Program for Children with Medical Complexity.

    Curfman AL, Haycraft M, McSwain SD, et al.

    Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2023; (29(6)):947-953 doi:10.1089/tmj.2022.0344.

    PMID: 36355064
  16. 16

    Artificial Intelligence in Rare Diseases: Workflow-Integrated Precision Kidney Care.

    Thongprayoon C, Pesce F, Cheungpasitporn W

    Clinics and practice 2026; (16(6)) doi:10.3390/clinpract16060101.

    PMID: 42346184
  17. 17

    Phenotype with a side of genotype, please: Patients, parents and priorities in rare genetic disease.

    Collins C

    Applied & translational genomics 2016; (8()):42-4 doi:10.1016/j.atg.2016.01.002.

    PMID: 27047761
  18. 18

    Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.

    Laurie S, Steyaert W, de Boer E, et al.

    Nature medicine 2025; (31(2)):478-489 doi:10.1038/s41591-024-03420-w.

    PMID: 39825153
  19. 19

    International Undiagnosed Diseases Programs (UDPs): components and outcomes.

    Curic E, Ewans L, Pysar R, et al.

    Orphanet journal of rare diseases 2023; (18(1)):348 doi:10.1186/s13023-023-02966-1.

    PMID: 37946247
  20. 20

    Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases.

    Epps C, Bax R, Croker A, et al.

    Therapeutic innovation & regulatory science 2022; (56(6)):964-975 doi:10.1007/s43441-022-00409-w.

    PMID: 35471559

This page is for informational purposes only and does not constitute medical advice. Use it to discuss care coordination with your child's pediatrician and specialist team.

Guide contents Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome
Research & Literature
05 Craniofacial and Neurological Care